These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


361 related items for PubMed ID: 9199708

  • 1. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M, Petríková M, Zatovicová M, Soláriková L, Kostolanský F, Mucha V, Russ G.
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [Abstract] [Full Text] [Related]

  • 2. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 3. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.
    Sanna PP, De Logu A, Williamson RA, Hom YL, Straus SE, Bloom FE, Burton DR.
    Virology; 1996 Jan 01; 215(1):101-6. PubMed ID: 8553581
    [Abstract] [Full Text] [Related]

  • 4. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J, Kees U, Kümel G, Kirchner H, Krammer PH.
    J Immunol; 1985 Jul 01; 135(1):575-82. PubMed ID: 2582051
    [Abstract] [Full Text] [Related]

  • 5. Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy.
    Liu K, Jiang D, Zhang L, Yao Z, Chen Z, Yu S, Wang X.
    Vaccine; 2012 Apr 19; 30(19):3034-41. PubMed ID: 22008818
    [Abstract] [Full Text] [Related]

  • 6. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT.
    J Immunol; 1995 Jul 01; 155(1):259-65. PubMed ID: 7602102
    [Abstract] [Full Text] [Related]

  • 7. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL, Duncan BE, Raybould TJ, Watson DH.
    J Gen Virol; 1985 May 01; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [Abstract] [Full Text] [Related]

  • 8. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
    Rajcáni J, Sabó A, Mucha V, Kostál M, Compel P.
    Acta Virol; 1995 Feb 01; 39(1):37-49. PubMed ID: 7572468
    [Abstract] [Full Text] [Related]

  • 9. Prevention of herpes keratitis by monoclonal antibodies specific for discontinuous and continuous epitopes on glycoprotein D.
    Lousch RN, Staats H, Oakes JE, Cohen GH, Eisenberg RJ.
    Invest Ophthalmol Vis Sci; 1991 Sep 01; 32(10):2735-40. PubMed ID: 1716618
    [Abstract] [Full Text] [Related]

  • 10. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG, Dollery SJ, Doyle JL, Nicola AV.
    Virology; 2008 Dec 20; 382(2):207-16. PubMed ID: 18950828
    [Abstract] [Full Text] [Related]

  • 11. Passive immune protection by herpes simplex virus-specific monoclonal antibodies with different plaque development inhibition activity.
    Mannini-Palenzona A, Costanzo F, Cassai E, Campana G.
    New Microbiol; 1993 Jul 20; 16(3):205-13. PubMed ID: 8396193
    [Abstract] [Full Text] [Related]

  • 12. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R, Wang L, Xu H, Wang Z, Zhang T, Wang M, Ning Y, Deng F, Hu Z, Wang H, Li Y.
    Antiviral Res; 2017 Nov 20; 147():131-141. PubMed ID: 29061442
    [Abstract] [Full Text] [Related]

  • 13. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
    Novotny MJ, Parish ML, Spear PG.
    Virology; 1996 Jul 01; 221(1):1-13. PubMed ID: 8661409
    [Abstract] [Full Text] [Related]

  • 14. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC.
    J Virol; 1985 Dec 01; 56(3):930-7. PubMed ID: 2415719
    [Abstract] [Full Text] [Related]

  • 15. Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2.
    Bystrická M, Vancíková M, Kasalová M, Rajcáni J, Kostál M, Murányiová M, Poláková K, Russ G.
    Acta Virol; 1991 Apr 01; 35(2):152-64. PubMed ID: 1681713
    [Abstract] [Full Text] [Related]

  • 16. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, Yamagishi H, Gojo S, Kita M, Imanishi J, Mazda O.
    Gene Ther; 2003 Dec 01; 10(25):2059-66. PubMed ID: 14595378
    [Abstract] [Full Text] [Related]

  • 17. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
    Komala Sari T, Gianopulos KA, Nicola AV.
    J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826995
    [Abstract] [Full Text] [Related]

  • 18. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ, Morrison LA, Knipe DM.
    Virology; 2001 Sep 30; 288(2):256-63. PubMed ID: 11601897
    [Abstract] [Full Text] [Related]

  • 19. Characterization of B virus glycoprotein antibodies induced by DNA immunization.
    Perelygina L, Patrusheva I, Zurkuhlen H, Hilliard JK.
    Arch Virol; 2002 Nov 30; 147(11):2057-73. PubMed ID: 12417944
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S, Franchini M, Alber G, Ackermann M, Suter M.
    J Virol; 2001 Oct 30; 75(20):9596-600. PubMed ID: 11559791
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.